PUBLISHER: The Business Research Company | PRODUCT CODE: 1942622
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942622
Coronary atherectomy devices serve the purpose of removing atherosclerosis from coronary blood vessels. These devices are specifically engineered to eliminate atheroma, calcium, and excess cellular material from areas of coronary occlusion or stenosis.
The primary products in coronary atherectomy devices include directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, among others. Rotational atherectomy devices, for instance, consist of a lengthy catheter housing a microscopic diamond-embedded, oval-shaped burr for the purpose of effectively addressing coronary conditions. These devices are widely utilized across various applications such as peripheral vascular, cardiovascular, and neurovascular treatments. They are employed by a range of end-users, including hospitals, surgical centers, ambulatory care facilities, research laboratories, and academic institutes.
Tariffs are impacting the coronary atherectomy devices market by increasing costs of imported precision motors, micro-drives, catheters, sensors, and specialty metals used in atherectomy systems. Hospitals and cardiac surgical centers in North America and Europe are most affected due to dependence on imported high-precision cardiovascular devices, while Asia-Pacific faces pricing pressure on device manufacturing and exports. These tariffs are raising procedure costs and slowing adoption in cost-sensitive markets. However, they are also encouraging regional manufacturing, local assembly of components, and innovation in cost-efficient atherectomy device designs.
The coronary atherectomy devices market research report is one of a series of new reports from The Business Research Company that provides coronary atherectomy devices market statistics, including coronary atherectomy devices industry global market size, regional shares, competitors with a coronary atherectomy devices market share, detailed coronary atherectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the coronary atherectomy devices industry. This coronary atherectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The coronary atherectomy devices market size has grown rapidly in recent years. It will grow from $0.23 billion in 2025 to $0.26 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to rising incidence of coronary artery disease, increased use of interventional cardiology procedures, expansion of catheterization laboratories, growing aging population, clinical validation of atherectomy techniques.
The coronary atherectomy devices market size is expected to see strong growth in the next few years. It will grow to $0.37 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing demand for complex coronary interventions, rising adoption of image-guided cardiovascular procedures, growing investments in cardiac care infrastructure, technological advancements in device precision, expansion of minimally invasive treatment protocols. Major trends in the forecast period include increasing use of advanced rotational atherectomy devices, rising adoption of minimally invasive coronary procedures, growing focus on calcified lesion treatment, expansion of precision-controlled atherectomy systems, enhanced integration with imaging-guided interventions.
The increasing prevalence of cardiovascular diseases (CVDs) is driving the growth of the coronary atherectomy devices market going forward. Cardiovascular diseases encompass a group of disorders affecting the heart and blood vessels, often resulting from plaque buildup, restricted blood flow, and progressive arterial narrowing. The rising burden of CVDs is largely attributed to the growing prevalence of modifiable risk factors such as hypertension, obesity, diabetes, unhealthy diets, physical inactivity, and tobacco use. This expanding disease burden is increasing the demand for coronary atherectomy devices, as these minimally invasive tools are critical for effectively removing calcified or complex plaque, restoring optimal blood flow, and improving procedural success rates during percutaneous coronary interventions (PCI). For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based public health institute, in 2023, approximately 1 out of every 6 deaths from cardiovascular diseases occurred among adults younger than 65 years, and a total of 919,032 people died from cardiovascular disease, accounting for 1 in every 3 deaths. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the global coronary atherectomy devices market.
Leading companies in the coronary atherectomy equipment market are emphasizing innovative solutions, such as radial access catheters, to enhance patient outcomes by enabling safer and less invasive treatments for coronary artery disease. Radial access catheters are specialized devices used in interventional cardiology to access coronary arteries via the radial artery in the wrist, as opposed to the traditional femoral artery in the groin. For example, in January 2024, AngioDynamics, a US-based provider of healthcare products and solutions, received FDA 510(k) clearance for its Auryon XL Radial Access Catheter, developed for the treatment of peripheral arterial disease (PAD). This 225-cm catheter, compatible with the Auryon Atherectomy System, is available in two diameters (0.9 mm and 1.5 mm) and leverages advanced laser technology for effective arterial occlusion treatment. Radial access offers significant advantages, including a lower risk of major bleeding compared to femoral access and the ability to treat bilateral disease in a single session, facilitating quicker patient recovery.
In April 2023, Abbott Laboratories, a US-based medical device firm, finalized the acquisition of Cardiovascular Systems, Inc. for $890 million. Through this acquisition, Abbott aims to enhance their capacity to cater to patients dealing with peripheral and coronary artery disease, particularly by preparing the arteries for angioplasty or stenting procedures to restore adequate blood flow. Cardiovascular Systems, Inc., a US-based medical device company, specializes in developing advanced treatments for coronary artery disease and challenging peripheral vascular conditions.
Major companies operating in the coronary atherectomy devices market are Boston Scientific Corporation, Cardiovascular Systems Inc., The Spectranetics Corporation, Medtronic Inc., Avinger Inc., Biotronik SE & Co. KG, Arterial Remodeling Technologies, Straub Medical AG, RA Medical Systems Inc., Shockwave Medical Inc., Terumo Corporation, Abbott Laboratories Inc., Asahi Intecc Co. Ltd., Baylis Medical Company Inc., Cook Medical LLC, Cordis Corporation, Infraredx Inc., Intact Vascular Inc., TriReme Medical LLC, Volcano Corporation
North America was the largest region in the coronary atherectomy devices market in 2025. Western Europe was the second-largest region in the global coronary atherectomy devices market share. Africa, was the smallest region in the coronary atherectomy devices industry. The regions covered in the coronary atherectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the coronary atherectomy devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The coronary atherectomy devices market consists of sales of directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, and others that are used to treat coronary atherectomy. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Coronary Atherectomy Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses coronary atherectomy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for coronary atherectomy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The coronary atherectomy devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.